论文部分内容阅读
目的探讨丁苯酞胶囊治疗急性脑梗死的临床效果。方法选取侯马市人民医院2014年1月—2015年1月收治的急性脑梗死患者60例,按照就诊顺序分成对照组和试验组,每组30例。对照组患者给予常规治疗,试验组患者给予丁苯酞胶囊治疗,疗程均为半个月。比较两组患者的治疗效果、治疗前后神经功能缺损(NIHSS)评分及不良反应发生情况。结果试验组治疗总有效率为93.3%(28/30),高于对照组的73.3%(22/30),治疗后试验组NIHSS评分低于对照组,差异有统计学意义(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论丁苯酞胶囊治疗急性脑梗死的效果确切,安全性好。
Objective To investigate the clinical effect of butylphthalide capsules in the treatment of acute cerebral infarction. Methods Sixty patients with acute cerebral infarction who were treated in Houma Municipal People’s Hospital from January 2014 to January 2015 were divided into control group and experimental group according to the order of treatment, with 30 cases in each group. Patients in the control group were given routine treatment. Patients in the test group were treated with butylphthalide capsules for half a month. The therapeutic effects of the two groups were compared, NIHSS scores and adverse reactions before and after treatment were compared. Results The total effective rate of the experimental group was 93.3% (28/30), higher than that of the control group (73.3%, 22/30). After treatment, the NIHSS score of the experimental group was lower than that of the control group (P <0.05) . Two groups of patients with adverse reactions, the difference was not statistically significant (P> 0.05). Conclusion Butylphthalide capsules for the treatment of acute cerebral infarction exact, safe.